CLX Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

99.480

Open

99.000

VWAP

97.96

Vol

2.14M

Mkt Cap

11.78B

Low

97.000

Amount

209.44M

EV/EBITDA(TTM)

11.43

Total Shares

120.92M

14.81B

EV/OCF(TTM)

25.71

P/S(TTM)

1.76

The Clorox Company is a multinational manufacturer and marketer of consumer and professional products. Its brands include Brita, Burt's Bees, Clorox, Fresh Step, Glad, Hidden Valley, Kingsford, Liquid-Plumr, Pine-Sol and Purell as well as international brands such as Chux, Clorinda and Poett. Its segments include Health and Wellness, Household, Lifestyle and International. Health and Wellness segment consists of cleaning, disinfecting and professional products marketed and sold in the United States. Products within this segment include home care, cleaning and disinfecting products and laundry additives; professional cleaning and disinfecting products, and others. Household segment consists of bags and wraps, cat litter and grilling products marketed and sold in the United States. Lifestyle segment consists of food, water filtration and natural personal care products marketed and sold in the United States. International segment consists of products sold outside the United States.

Events Timeline

(ET)

2026-06-17

16:30:00

Clorox Simplifies Operating Structure, Appoints New COO

2026-05-28 (ET)

2026-05-28

16:10:00

Clorox CEO Linda Rendle Steps Down for Health Reasons

2026-05-01 (ET)

2026-05-01

09:00:00

Apple Stock Rises 3% Driven by Strong Earnings

News

9.5

07-07Fool

Colgate-Palmolive Forecasts Continued Growth Amid Market Challenges

2.0

07-07NASDAQ.COM

Colgate-Palmolive's Resilience Amid Market Challenges

8.5

07-05NASDAQ.COM

Investment Opportunities in McDonald's, Clorox, and General Mills

8.5

07-05Fool

Investment Opportunities in McDonald's, Clorox, and General Mills

2.0

06-25NASDAQ.COM

Market Capitalization Comparison: Revvity vs Clorox

8.5

06-21Fool

Top Dividend Stocks to Hold for the Next Decade

14 Analyst Rating

Wall Street analysts forecast CLX stock price to rise

1 Buy

10 Hold

3 Sell

Hold

Current: 0.000

Low

94.00

Averages

118.69

High

152.00

Current: 0.000

Low

94.00

Averages

118.69

High

152.00

Goldman Sachs

Bonnie Herzog

Sell

downgrade

$94 -> $83

AI Analysis

2026-05-01

Reason

Goldman Sachs

Bonnie Herzog

Price Target

$94 -> $83

AI Analysis

2026-05-01

downgrade

Sell

Reason

Goldman Sachs analyst Bonnie Herzog lowered the firm's price target on Clorox to $83 from $94 and keeps a Sell rating on the shares. Clorox reported a slight EPS beat for Q3 but issued weaker FY26 guidance and a complex outlook citing oil and gas-driven cost pressures, soft consumer and scanner trends, incremental headwinds from Middle East conflict, ERP transition impacts, and integration of the Purell acquisition, ultimately leading to a disappointing overall update, the analyst tells investors in a research note.

Morgan Stanley

Equal Weight

downgrade

$110 -> $97

2026-05-01

Reason

Morgan Stanley

Price Target

$110 -> $97

2026-05-01

downgrade

Equal Weight

Reason

Morgan Stanley lowered the firm's price target on Clorox to $97 from $110 and keeps an Equal Weight rating on the shares. Sales struggles are persisting, particularly in litter and salad dressing, and cost pressures are ramping with limited pricing offsets, meaning consensus needs to come down, the analyst tells investors.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CLX

Unlock Now

Valuation Metrics

The current forward P/E ratio for Clorox Co (CLX.N) is 15.43, compared to its 5-year average forward P/E of 25.52. For a more detailed relative valuation and DCF analysis to assess Clorox Co's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

25.52

Current PE

15.43

Overvalued PE

31.84

Undervalued PE

19.20

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

16.59

Current EV/EBITDA

9.86

Overvalued EV/EBITDA

19.91

Undervalued EV/EBITDA

13.27

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

2.45

Current PS

1.54

Overvalued PS

2.81

Undervalued PS

2.10

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

Best paying monthly dividend stock?

Intellectia · 32 candidates

Market Cap: >= 1000.00MDividend Yield Ttm: 4 - 10Beta: LowRisk, ModerateRisk, HighRiskDividend Payout Ratio: 40.00 - 90.00Dividend 5yr Cagr: >= 2

Ticker

Name

Market Cap$

ITUB

Itau Unibanco Holding SA

102.11B

WEN

Wendy's Co

1.47B

DCOM

Dime Community Bancshares Inc

1.46B

CRI

Carter's Inc

1.53B

BBDO

Banco Bradesco SA

38.50B

BBD

Banco Bradesco SA

42.84B

What stocks do the best in December

Intellectia · 85 candidates

Market Cap: >= 10.00BSector: Consumer Cyclicals, Consumer Non-Cyclicals, RetailersAnnual Eps Yoy Growth: >= 0.0%

Ticker

Name

Market Cap$

BROS

Dutch Bros Inc

10.07B

JBS

Jbs NV

16.92B

CHWY

Chewy Inc

13.43B

COKE

Coca-Cola Consolidated Inc

10.26B

Hyatt Hotels Corp

15.55B

CMI

Cummins Inc

80.34B

Whales Holding CLX

Quinn Opportunity Partners LLC

ICICI Prudential Asset Management Company Limited

Trading Trends

People Also Watch

Frequently Asked Questions

What is Clorox Co (CLX) stock price today?

The current price of CLX is 97.41 USD — it has increased 0.16

What is Clorox Co (CLX)'s business?

What is the price predicton of CLX Stock?

Wall Street analysts forecast CLX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLX is118.69 USD with a low forecast of 94.00 USD and a high forecast of 152.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.